Top 10 most funded health tech startups in MENA region

When quarantines and social distancing became a daily norm, people used digital technologies to interact with the world, especially in healthcare. (Supplied)
Short Url
Updated 16 October 2022
Follow

Top 10 most funded health tech startups in MENA region

  • Healthcare industry has given rise to newer business models such as telehealth

CAIRO: In a post-pandemic era, people have never been more aware of their wellness, including physical well-being and prevalent health issues.

COVID-19, on the other hand, had a significant effect on technology.

When quarantines and social distancing became a daily norm, people used digital technologies to interact with the world, especially in healthcare.

The result: The healthcare industry became one of the fastest growing sectors in the world and gave rise to newer business models such as telehealth and next-gen managed care. Arab News compiled a list of the top 10 most funded health-tech startups in the Middle East and North Africa region.

Vezeeta

Total funding: $73 million

Founders: Amir Barsoum and Ahmed Badr

Investors: BECO Capital, Silicon Badia, Vostok New Ventures, Crescent Enterprises’ CE-Ventures, Endeavour Catalyst and STV

Headquarters: Egypt

Founded in 2012, Vezeeta offers appointment management software for doctors and healthcare providers to manage their operations better.

The company also provides patients with a free platform to book their appointments, as doctors can opt for the platform using a subscription model.

In 2020, Vezeeta managed to secure $40 million in a series D funding round to roll out new products and introduce its telehealth services.

Altibbi

Total funding: $52.5 million

Founders: Jalil Labadi and Abdel Aziz Labadi

Investors: Foundation Holdings, Hikma Ventures, Global Ventures and DASH Ventures

Headquarters: UAE

Founded in 2008, Atlibbi is a digital platform that allows users to receive remote medical consultations and connect with professionals via calls and text chats.

The company has over 10,000 doctors on its platform and won the World Summit Award for the Best Digital Health Content Award and the Schwab Foundation for Social Entrepreneurship.

In its latest funding round, Altibbi raised $44 million in a series B funding round in March 2022 to enhance its technology and e-pharmacy services.

Bayzat

Total funding: $31 million

Founders: Talal Bayaa, Tarek Bayaa and Brian Habibi

Investors: Mohammed Bin Rashid Innovation Fund, Point72 Ventures, Mubadala, Beco Capital, Silicon Badia and Hamed Kanoo Co.

Headquarters: UAE

Founded in 2013, Bayzat is a web and mobile application that allows clients to buy and sell health insurance.

The company’s health tech platform compares health insurance and offers them the best options. Raising $16 million in a series B funding round in 2019, the company used its funding to empower its technology to serve its clients better.

It also provides HR solutions for companies.

GluCare Health

Total funding: $20 million

Founders: Ali Hashemi and Ihsan Almarzooqi

Investors: Polymath Ventures

Headquarters: UAE

Founded in 2020, GluCare offers diabetic care in the clinic and virtually for its patients using its data monitoring and artificial intelligence.

With the company’s application, patients can connect with a care team to monitor glucose, insulin, diet intake and more. 

Selfologi

Total funding: $18 million

Founder: Tamer Wali

Investors: Xenel

Headquarters: UAE

Founded in 2020, Selfologi is an online platform for aesthetic medical treatments that allows users to book appointments with doctors in fields like botox, hair removal, acne scarring and more.

The company raised its $18 million investment in a round led by its founder and angel investor, Tamer Wali, with participation from Xenel international group. 




Tamer Wali, founder of Selfologi.

Okadoc

Total funding: $12 million

Founders: Fodhil Benturquia

Investors: Abu Dhabi Investment Office, Ithmar Capital and iGan Partners

Headquarters: UAE

Founded in 2018, Okadoc is an appointment booking platform provider that allows people to search for the nearest clinic, practitioners and hospitals.

In 2020, the company closed its $10 million series A funding, expanded its operations and promoted its telehealth offering and virtual consultations.

Yodawy

Total funding: $8.5 million

Founders: Karim Khashaba, Yasser AbdelGawad and Sherief El-Feky

Investors: Global Ventures, MEVP, Algebra Ventures, CVentures, P1 Ventures and Athaal Angel Investors Group

Headquarters: Egypt

Founded in 2018, Yodawy is a virtual pharmacy providing a marketplace for people who want access to medication with over 3,000 pharmacies.

In mid-2021, the company secured $7.5 million in a series B funding round to build its digital marketplace to serve its wide range of customers.

Aumet

Total funding: $8.5 million

Founders: Yahya Aqel and Shahed Altawafsheh

Investors: 500 Startups, Right side capital, TechStars, Shorooq Partners and Plug and Play

Headquarters: Saudi Arabia and Jordan

Established in 2020, Aumet is a B2B marketplace for healthcare providers to buy supplies from retailers. In 2020, the company raised $1.25 million in a seed funding round and had not disclosed its later investments.

Webteb

Total funding: $5.1 million

Founders: Majed Abukhater and Mahmoud Kayal

Investors: Sadara Ventures and Siraj Palestine Fund

Headquarters: Jordan

Founded in 2011, Webteb is an online platform that provides health news, medical information, and lifestyle-related topics.

The company raised $3.2 million in its series C investment round to fuel regional expansion.

Health at Hand

Total funding: $4 million

Founder: Charlie Barlow

Investors: Simon Charlton and Rockfirst Capital

Headquarters: UAE

Born in 2015, Health at Hand is a mobile application that facilitates virtual consultations for patients with nonemergency conditions like colds, coughs and others.

The company raised its total funding in a seed round in 2017 to develop its technology further and introduce its subscription-based model.


Saudi Maaden reports 156% profit surge to $2bn on strong commodity prices, record production

Updated 05 March 2026
Follow

Saudi Maaden reports 156% profit surge to $2bn on strong commodity prices, record production

RIYADH: Saudi mining and metals company Maaden has reported a 156 percent jump in its net profit attributable to shareholders for 2025, driven by higher commodity prices, record production volumes, and a one-off bargain purchase gain.

The state-backed giant posted a net profit of SR7.35 billion ($1.95 billion) for the full year 2025, an increase from SR2.87 billion in the previous year. The firm’s revenue surged by 19 percent to SR38.58 billion, up from SR32.55 billion in 2024.

This comes as Saudi Arabia steps up efforts to expand its mining sector as a pillar of economic diversification, encouraging international participation and private investment to unlock the Kingdom’s estimated $2.5 trillion in untapped mineral resources under Vision 2030.    

In a statement on Tadawul, the company said: “Performance was led by record phosphate production, near record aluminum production, an increase in all three of Maaden’s main output commodity prices.”

The performance was also fueled by a 60 percent increase in gross profit, which reached SR14.79 billion. In its annual results announcement, Maaden attributed the top-line growth to “higher commodity market prices for phosphate, aluminum and gold business units,” as well as increased sales volumes in its phosphate and aluminum segments. This was partially offset by slightly lower sales volume in the gold unit.

Maaden’s CEO, Bob Wilt, hailed 2025 as a transformative year for the company, marked by strategic growth and operational excellence. “This was a great year for Maaden’s strategic growth. We delivered strong financial results and sustained operational excellence across the business,” he said in a statement.

“This was driven by growth in production across all businesses, including record-breaking DAP (di-ammonium phosphatevolumes), disciplined cost control across and a clear commitment to our role as a cornerstone of the Saudi economy,” Wilt added.

Profitability was further bolstered by an increased share of net profit from joint ventures and an associate. This included a one-off bargain purchase gain of SR768 million related to Maaden’s investment in Aluminium Bahrain B.S.C. The company also benefited from lower finance costs.

The fourth quarter of 2025 was strong, with Maaden swinging to a net profit of SR1.67 billion, compared to a loss of SR106 million in the same period of the prior year. Quarterly revenue rose 7 percent to SR10.64 billion.

The firm achieved record production of di-ammonium phosphate, reaching 6.72 million tonnes for the year, a 9 percent increase. Aluminum production remained near-record levels, while the company added a net 7.8 million ounces to its reportable gold mineral resources through discovery and resource development.

The phosphate division saw sales jump 17 percent to SR20.77 billion, with the earnings before interest, taxes, depreciation, and amortization margin expanding to 47 percent. The aluminum business reported a 9 percent increase in sales to SR10.99 billion, with EBITDA more than doubling in the fourth quarter.

Looking ahead, Wilt emphasized that the pace of growth will accelerate as the company advances key initiatives, including the Phosphate 3 Phase 1 and Ar Rjum projects, which remain on budget and schedule. Maaden has also secured a gas supply for its future Phosphate 4 project.

“This pace of growth will only accelerate. Not only as we advance projects and increase the scale of our exploration program, but as we continue to grow production and implement technology that will further modernize, streamline and unlock value,” Wilt added.

Earnings per share for the year rose sharply to SR1.91, up from SR0.78 in 2024. Total shareholders’ equity increased by 18.7 percent to SR61.59 billion.